Control of type II transforming growth factor-β receptor expression by integrin ligation

被引:45
|
作者
Wang, DH
Sun, LZ
Zborowska, E
Willson, JKV
Gong, JG
Verraraghavan, J
Brattain, MG
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Surg, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA
[3] Univ Kentucky, Dept Pharmacol, Lexington, KY 40536 USA
[4] Case Western Reserve Univ, Ireland Canc Ctr, Dept Med, Cleveland, OH 44106 USA
[5] Sch Med, Cleveland, OH 44106 USA
[6] Med Coll Ohio, Dept Biochem, Toledo, OH 43699 USA
关键词
D O I
10.1074/jbc.274.18.12840
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ectopic expression of the alpha(5) integrin subunit in cancer cells with little or no endogenous expression of this integrin often results in reduced proliferation as well as reduced malignancy, We now show that inhibition resulting from ectopic expression of alpha(5) integrin is due to induction of autocrine negative transforming growth factor-beta (TGF-beta) activity. MCF-7 breast cancer cells do not express either alpha(5) integrin or type II TGF-beta receptor and hence are unable to generate TGF-beta signal transduction. Ectopic expression of cy,integrin expression enhanced cell adhesion to fibronectin, reduced proliferation, and increased the expression of type II TGF-beta receptor mRNA and cell surface protein. Receptor expression was increased to a higher level in alpha(5) transfectants by growth on fibronectin-coated plates. Induction of type II TGF-beta receptor expression also resulted in the generation of autocrine negative TGF-beta activity because colony formation was increased after TGF-beta neutralizing antibody treatment. Transient transfection with a TGF-beta promoter response element in tandem with a luciferase cDNA into cells stably transfected with cu, integrin resulted in basal promoter activities 5-10-fold higher than those of control cells. Moreover, when alpha(5) transfectants were treated with a neutralizing antibody to either TGF-beta or integrin alpha(5), this increased basal promoter activity was blocked, Autocrine TGF-beta activity also induced 3-fold higher endogenous fibronectin expression in alpha(5) transfectants relative to that of control cells, Re-expression of type II receptor by alpha(5) transfection also restored the ability of the cells to respond to exogenous TGF-beta and led to reduced tumor growth in athymic nude mice. Taken together, these results show for the first time that TGF-beta type II receptor expression can be controlled by alpha(5)beta(1) ligation and integrin signal transduction, Moreover, TGF-beta and integrin signal transduction appear to cooperate in their tumor-suppressive functions.
引用
收藏
页码:12840 / 12847
页数:8
相关论文
共 50 条
  • [31] Transforming growth factor-β isoform and receptor expression in chondrosarcoma of bone
    Masi, L
    Malentacchi, C
    Campanacci, D
    Franchi, A
    VIRCHOWS ARCHIV, 2002, 440 (05) : 491 - 497
  • [32] Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells
    Ko, Y
    Banerji, SS
    Liu, Y
    Li, WH
    Liang, JR
    Soule, HD
    Pauley, RJ
    Willson, JKV
    Zborowska, E
    Brattain, MG
    JOURNAL OF CELLULAR PHYSIOLOGY, 1998, 176 (02) : 424 - 434
  • [33] Transforming growth factor-β receptor expression on human skin fibroblasts:: Dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-β binding proteins
    Tam, BYY
    Philip, A
    JOURNAL OF CELLULAR PHYSIOLOGY, 1998, 176 (03) : 553 - 564
  • [34] Enhanced tumorigenesis and reduced transforming growth factor-β type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-β1
    Kang, Y
    Mariano, JM
    Angdisen, J
    Moody, TW
    Diwan, BA
    Wakefield, LM
    Jakowlew, SB
    MOLECULAR CARCINOGENESIS, 2000, 29 (02) : 112 - 126
  • [35] Expression of transforming growth factor-α and epidermal growth factor receptor in gastrointestinal stromal tumours
    Cai, YC
    Jiang, Z
    Vittimberga, F
    Xu, XW
    Savas, L
    Woda, B
    Callery, M
    Banner, B
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (02): : 112 - 115
  • [36] Expression of transforming growth factor-α and epidermal growth factor receptor in gastrointestinal stromal tumours
    Yun-Cai Cai
    Zhong Jiang
    Frank Vittimberga
    Xiaowen Xu
    L. Savas
    Bruce Woda
    Mark Callery
    B. Banner
    Virchows Archiv, 1999, 435 : 112 - 115
  • [37] Expression of transforming growth factor-β receptor type 1 and type 2 in human sporadic vestibular Schwannoma
    Loettrich, Mathias
    Mawrin, Christian
    Chamaon, Kathrin
    Kirches, Elmar
    Dietzmann, Knut
    Freigang, Bernd
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (04) : 245 - 249
  • [38] Reduced transforming growth factor-β receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis
    Mamiya, Takao
    Yamazaki, Ken
    Masugi, Yohei
    Mori, Taisuke
    Effendi, Kathryn
    Du, Wenlin
    Hibi, Taizo
    Tanabe, Minoru
    Ueda, Masakazu
    Takayama, Tadatoshi
    Sakamoto, Michiie
    LABORATORY INVESTIGATION, 2010, 90 (09) : 1339 - 1345
  • [39] Expression of transforming growth factor β1 and transforming growth factor β type-II receptor mRNA in papillary thyroid carcinoma
    Matoba, H
    Sugano, S
    Yamaguchi, N
    Miyachi, Y
    HORMONE AND METABOLIC RESEARCH, 1998, 30 (10) : 624 - 628
  • [40] Isolation and characterization of a transforming growth factor-β Type II receptor cDNA from Xenopus laevis
    Dhanasekaran, SM
    Vempati, UD
    Kondaiah, P
    GENE, 2001, 263 (1-2) : 171 - 178